DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bartlett JM, Munro AF, Dunn JA et al.
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).
Lancet Oncol 2010;
11: 266-274
DOI: 10.1016/S1470-2045(10)70006-1.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.